3362 related articles for article (PubMed ID: 7716716)
1. Immunoregulatory effects of CD4+ T helper subsets in human melanoma.
Lee KY; Goedegebuure PS; Linehan DC; Eberlein TJ
Surgery; 1995 Apr; 117(4):365-72. PubMed ID: 7716716
[TBL] [Abstract][Full Text] [Related]
2. Classification of CD4+ T helper cell clones in human melanoma.
Goedegebuure PS; Lee KY; Matory YL; Peoples GE; Yoshino I; Eberlein TJ
Cell Immunol; 1994 Jun; 156(1):170-9. PubMed ID: 7911074
[TBL] [Abstract][Full Text] [Related]
3. Multiple sub-sets of CD4+ and CD8+ cytotoxic T-cell clones directed to autologous human melanoma identified by cytokine profiles.
Maccalli C; Mortarini R; Parmiani G; Anichini A
Int J Cancer; 1994 Apr; 57(1):56-62. PubMed ID: 7908659
[TBL] [Abstract][Full Text] [Related]
4. Defective lymphokine production by most CD8+ and CD4+ tumor-specific T cell clones derived from human melanoma-infiltrating lymphocytes in response to autologous tumor cells in vitro.
Guilloux Y; Viret C; Gervois N; Le Dréan E; Pandolfino MC; Diez E; Jotereau F
Eur J Immunol; 1994 Sep; 24(9):1966-73. PubMed ID: 7522155
[TBL] [Abstract][Full Text] [Related]
5. Human allogeneic melanoma-reactive T-helper lymphocyte clones: functional analysis of lymphocyte-melanoma interactions.
Radrizzani M; Benedetti B; Castelli C; Longo A; Ferrara GB; Herlyn M; Parmiani G; Fossati G
Int J Cancer; 1991 Dec; 49(6):823-30. PubMed ID: 1835714
[TBL] [Abstract][Full Text] [Related]
6. Characterization of autologous tumor-specific T-helper 2 cells in tumor-infiltrating lymphocytes from a patient with metastatic melanoma.
Kharkevitch DD; Seito D; Balch GC; Maeda T; Balch CM; Itoh K
Int J Cancer; 1994 Aug; 58(3):317-23. PubMed ID: 7914181
[TBL] [Abstract][Full Text] [Related]
7. Functional heterogeneity among herpes simplex virus-specific human CD4+ T cells.
Yasukawa M; Inatsuki A; Horiuchi T; Kobayashi Y
J Immunol; 1991 Feb; 146(4):1341-7. PubMed ID: 1671404
[TBL] [Abstract][Full Text] [Related]
8. CD40-ligated dendritic cells effectively expand melanoma-specific CD8+ CTLs and CD4+ IFN-gamma-producing T cells from tumor-infiltrating lymphocytes.
Terheyden P; Straten P; Bröcker EB; Kämpgen E; Becker JC
J Immunol; 2000 Jun; 164(12):6633-9. PubMed ID: 10843723
[TBL] [Abstract][Full Text] [Related]
9. CD4+ T cell clones isolated from human renal cell carcinoma possess the functional characteristics of Th2 helper cells.
Schoof DD; Terashima Y; Peoples GE; Goedegebuure PS; Andrews JV; Richie JP; Eberlein TJ
Cell Immunol; 1993 Aug; 150(1):114-23. PubMed ID: 8102084
[TBL] [Abstract][Full Text] [Related]
10. Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma.
Mukherji B; Guha A; Chakraborty NG; Sivanandham M; Nashed AL; Sporn JR; Ergin MT
J Exp Med; 1989 Jun; 169(6):1961-76. PubMed ID: 2471770
[TBL] [Abstract][Full Text] [Related]
11. Human atopen-specific types 1 and 2 T helper cell clones.
Wierenga EA; Snoek M; Jansen HM; Bos JD; van Lier RA; Kapsenberg ML
J Immunol; 1991 Nov; 147(9):2942-9. PubMed ID: 1680923
[TBL] [Abstract][Full Text] [Related]
12. MHC class-I-restricted auto-tumor-specific CD4+CD8- T-cell clones established from autologous mixed lymphocyte-tumor-cell culture (MLTC).
Wang P; Vánky F; Klein E
Int J Cancer; 1992 Jul; 51(6):962-7. PubMed ID: 1386348
[TBL] [Abstract][Full Text] [Related]
13. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10.
Gerosa F; Paganin C; Peritt D; Paiola F; Scupoli MT; Aste-Amezaga M; Frank I; Trinchieri G
J Exp Med; 1996 Jun; 183(6):2559-69. PubMed ID: 8676077
[TBL] [Abstract][Full Text] [Related]
15. Toxoplasma gondii-specific CD4+ T cell clones from healthy, latently infected humans display a Th0 profile of cytokine secretion.
Prigione I; Facchetti P; Ghiotto F; Tasso P; Pistoia V
Eur J Immunol; 1995 May; 25(5):1298-305. PubMed ID: 7774633
[TBL] [Abstract][Full Text] [Related]
16. Tumor-infiltrating CD4+ T lymphocytes express APO2 ligand (APO2L)/TRAIL upon specific stimulation with autologous lung carcinoma cells: role of IFN-alpha on APO2L/TRAIL expression and -mediated cytotoxicity.
Dorothée G; Vergnon I; Menez J; Echchakir H; Grunenwald D; Kubin M; Chouaib S; Mami-Chouaib F
J Immunol; 2002 Jul; 169(2):809-17. PubMed ID: 12097384
[TBL] [Abstract][Full Text] [Related]
17. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
[TBL] [Abstract][Full Text] [Related]
18. Selective expansion of a specific anti-tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor-infiltrating lymphocytes from a melanoma patient: cytotoxic activity and T cell receptor gene rearrangements.
Gervois N; Heuze F; Diez E; Jotereau F
Eur J Immunol; 1990 Apr; 20(4):825-31. PubMed ID: 1971794
[TBL] [Abstract][Full Text] [Related]
19. Lymphokine production by human melanoma tumor-infiltrating lymphocytes.
Salmeron MA; Morita T; Seki H; Platsoucas CD; Itoh K
Cancer Immunol Immunother; 1992; 35(3):211-7. PubMed ID: 1386286
[TBL] [Abstract][Full Text] [Related]
20. Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease.
Norose K; Yano A
Br J Ophthalmol; 1996 Nov; 80(11):1002-8. PubMed ID: 8976730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
